Genomenon

2:00 PM - 2:15 PM, Monday, June 3, 2019 ・ Theater 1
Genomenon connects patient’s DNA with the billions of dollars of genomic research to help doctors diagnose & cure cancer patients and babies with rare diseases, and researchers understand diseases at a molecular level. Our flagship product, the Mastermind Genomic Search Engine provides immediate insight into the published genomic research for every disease, gene, and mutation found through the full text of medical literature. The Mastermind Genomic Landscape provides the entire published genomic landscape of any disease. Pharmaceutical and bio-pharma researchers use Mastermind to understand diseases at a molecular level and to identify and prioritize genomic biomarkers for drug discovery and clinical trial targets.
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company Website:
Company HQ State:
Michigan
Company HQ Country:
United States
Year Founded:
2014
Main Therapeutic Focus:
Lead Product in Development:
TBD
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.
Speaker
photo
CEO
Genomenon